# Resmed fiscal first-quarter revenue rises 6% to $1.415 billion

> Resmed reported revenue of 1.415 billion dollars for the first quarter of fiscal 2027 on 29 October, up 6% from 1.336 billion dollars a year earlier. The quarter ended 30 September 2026; the fiscal-year label does not mean the results cover a period in calendar 2027.

- Canonical URL: https://newsverum.com/en/news/resmed-fiscal-2027-first-quarter-revenue-earnings
- Publisher: Newsverum
- Section: Business
- Country: United States
- Published: 2026-10-29T23:19:00+00:00
- Updated: 2026-10-29T23:19:00+00:00
- Event / data period: 2026-09-30
- Other editions: [Türkçe](https://newsverum.com/tr/news/resmed-fiscal-2027-first-quarter-revenue-earnings.md), [العربية](https://newsverum.com/ar/news/resmed-fiscal-2027-first-quarter-revenue-earnings.md), [Français](https://newsverum.com/fr/news/resmed-fiscal-2027-first-quarter-revenue-earnings.md), [Español](https://newsverum.com/es/news/resmed-fiscal-2027-first-quarter-revenue-earnings.md), [Deutsch](https://newsverum.com/de/news/resmed-fiscal-2027-first-quarter-revenue-earnings.md), [Português](https://newsverum.com/pt/news/resmed-fiscal-2027-first-quarter-revenue-earnings.md)

Reported diluted earnings per share were 2.92 dollars, up 23%, while non-GAAP diluted earnings were 2.91 dollars, up 14%. Reported gross margin was 61.5% and non-GAAP gross margin was 62.5%. Core constant-currency revenue growth was 7%, excluding currency effects, the Noctrix acquisition and the MatrixCare divestiture.

Operating cash flow was 422 million dollars and free cash flow was 374 million dollars for the quarter. The company maintained fiscal 2027 revenue guidance of 5.75–5.85 billion dollars and non-GAAP earnings guidance of 12.00–12.25 dollars per share. These annual ranges are forecasts and are distinct from the completed quarter’s results.

## Data

### Source publication

Publication of the official announcement on 29 October 2026.

Methodology: The date records publication of the cited primary source. Statistical reference periods and announced future actions are identified in the article.

| date | label | description | status |
|---|---|---|---|
| 2026-10-29 | Resmed fiscal first-quarter revenue rises 6% to $1.415 billion | Resmed reported revenue of 1.415 billion dollars for the first quarter of fiscal 2027 on 29 October, up 6% from 1.336 billion dollars a year earlier. The quarter ended 30 September 2026; the fiscal-year label does not mean the results cover a period in calendar 2027. | occurred |

Sources: <https://rss.globenewswire.com/news-release/2026/10/29/3391819/0/en/resmed-inc-announces-results-for-the-first-quarter-of-fiscal-year-2027.html> · Download data: [JSON](https://newsverum.com/api/v1/articles/resmed-fiscal-2027-first-quarter-revenue-earnings/data/source-announcement?lang=en&format=json) · [CSV](https://newsverum.com/api/v1/articles/resmed-fiscal-2027-first-quarter-revenue-earnings/data/source-announcement?lang=en&format=csv)

## Sources

- [Resmed, issuer release via GlobeNewswire](<https://rss.globenewswire.com/news-release/2026/10/29/3391819/0/en/resmed-inc-announces-results-for-the-first-quarter-of-fiscal-year-2027.html>) (Source checked: 2026-10-29; Published: 2026-10-29)

---

Cite the canonical URL above. [Editorial standards and corrections](https://newsverum.com/en/editorial)